protease inhibitors drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (13)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G. (2020)
- Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features. (2019)
- Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways. (2019)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
- Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
- Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
- Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| protease inhibitors | drug | 32 | 37 |